Considerations on equity in management of end-stage kidney disease in low- and middle-income countries

      Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.

      Keywords

      To read this article in full you will need to make a payment
      ISN Member Login
      ISN Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        Health equity.
        (Available at:)
        • Vandertol A.
        • Lameire N.
        • Morton R.L.
        • et al.
        An international analysis of dialysis services reimbursement.
        Clin J Am Soc Nephrol. 2019; 14: 84-93
        • Jha V.
        • Arici M.
        • Collins A.J.
        • et al.
        • for the KDIGO Conference Participants
        Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
        Kidney Int. 2016; 90: 1164-1174
        • Ashuntantang G.
        • Osafo C.
        • Olowu W.A.
        • et al.
        Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review.
        Lancet Glob Health. 2017; 5: e408-e417
        • Couser W.G.
        • Remuzzi G.
        • Mendis S.
        • et al.
        The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
        Kidney Int. 2011; 80: 1258-1270
        • Swanepoel C.R.
        • McCulloch M.I.
        • Abraham G.
        • et al.
        Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce.
        Kidney Int Suppl. 2020; 10: e49-e54
        • Pan American Health Organization Health Economics and Financing (HEF)
        Health care expenditure and financing in Latin America and the Caribbean (fact sheet), December 2012.
        (Available at:)
        • World Bank Group
        Countries and economies. Colombia.
        (Available at:)
        • World Bank Group
        Countries and economies. Mexico.
        (Available at:)
        • Guerrero R.
        • Prada S.I.
        • Perez A.M.
        • et al.
        Universal health coverage assessment. Colombia.
        (Available at:)
        • World Health Organization
        Global health expenditure database.
        (Available at:)
        • World Bank Group
        Countries and economies. South Africa.
        (Available at:)
        • Mills A.
        • Ally M.
        • Goudge J.
        • et al.
        Progress towards universal coverage: the health systems of Ghana, South Africa and Tanzania.
        Health Policy Plan. 2012; 27: i4-i12
        • World Health Organization
        African regional health expenditure dashboard.
        (Available at:)
        • World Bank Group
        Countries and economies. Thailand.
        (Available at:)
        • World Health Organization
        Health financing profile 2017. Thailand.
        (Available at:)
        • World Bank Group
        Countries and economies. India.
        (Available at:)
        • World Health Organization
        Health financing profile 2017. India.
        (Available at:)
        • Gupta I.
        • Bathia M.
        The Indian health care system.
        (Available at:)
      1. Cuenta de Alto Costo. Bogota: Fondo Colombiano de enfermedades de Alto Costo. Situacion de la enfermedad renal cronica, la hipertension arterial y la diabetes mellitus en Colombia, 2016.
        (Available at:)
        • Saran R.
        • Robinson B.
        • Abbott K.C.
        • et al.
        US Renal Data System 2016 annual data report: epidemiology of kidney disease in the United States.
        Am J Kidney Dis. 2017; 69: A7-A8
        • Lopera-Medina M.
        La enfermedad renal cronica en Colombia: necesidades en salud y respuesta del Sistema General de Seguridad Social en Salud.
        Rev Gerenc Polit Salud. 2016; 15: 212-233
        • Organization for Economic Cooperation and Development
        OECD reviews of health systems: Mexico 2016.
        (Available at:)
        • Frenk J.
        • González-Pier E.
        • Gómez-Dantés O.
        • et al.
        Comprehensive reform to improve health system performance in Mexico.
        Lancet. 2006; 368: 1524-1534
      2. Seguro Popular. Anexo I. Intervenciones del fondo de proteccion contra Gastos Catastroficos.
        (Available at:)
        • Garcia-Garcia G.
        • Chavez-Iñiguez J.S.
        The tragedy of having ESRD in Mexico.
        Kidney Int Rep. 2018; 3: 1027-1029
        • Davids M.
        • Marais N.
        • Jacobs J.
        South African Renal Registry annual report 2015.
        Afr J Nephrol. 2017; 20: 201-213
        • Moosa M.R.
        • Kidd M.
        The dangers of rationing dialysis treatment: the dilemma facing a developing country.
        Kidney Int. 2006; 70: 1107-1114
        • Moosa M.R.
        • Maree J.D.
        • Chirehwa M.T.
        • et al.
        Use of the 'accountability for reasonableness' approach to improve fairness in accessing dialysis in a middle-income country.
        PLoS One. 2016; 11e0164201
      3. Equitap. Equity in financing health care: impact of universal access to healthcare in Thailand.
        (Available at:)
        http://www.equitap.org/publications/docs/EquitapWP16.pdf
        Date: 2005
        Date accessed: November 18, 2018
        • Chuengsaman P.
        • Kasemsup V.
        PD first policy: Thailand's response to the challenge of meeting the needs of patients with end-stage renal disease.
        Semin Nephrol. 2017; 37: 287-295
        • Kumar V.
        • Jha V.
        End-stage renal disease care in South Asia: demographics, economics, and opportunities.
        Clin Nephrol. 2016; 86: 23-26
        • Essue B.M.
        • Jha V.
        • Oommen J.
        • et al.
        Universal health coverage and chronic kidney disease in India.
        Bull World Health Organ. 2018; 96: 442
        • Bradshaw C.
        • Gracious N.
        • Narayanan R.
        • et al.
        Paying for hemodialysis in Kerala, India: a description of household financial hardship in the context of medical subsidy.
        Kidney Int Rep. 2019; 4: 390-398
        • Shaikh M.
        • Woodward M.
        • Oommen J.
        • et al.
        Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.
        Kidney Int. 2018; 94: 440-445
        • Rosa-Diez G.
        • Gonzalez-Bedat M.
        • Ferreiro A.
        • et al.
        Burden of end-stage renal disease (ESRD) in Latin America.
        Clin Nephrol. 2016; 86: 29-33
        • Méndez-Durán A.
        • Ignorosa-Luna M.H.
        • Pérez-Aguilar G.
        • et al.
        Current status of alternative therapies renal function at the Instituto Mexicano del Seguro Social.
        Rev Med Inst Mex Seguro Soc. 2016; 54: 588-593
        • Garcia-Garcia G.
        • Garcia-Bejarano H.
        • Breien-Coronado H.
        • et al.
        End-stage renal disease in Mexico.
        in: Garcia-Garcia G. Agodoa L. Norris K. Chronic Kidney Disease in Disadvantaged Populations. Elsevier, New York, NY2017: 77-82
        • Cueto-Manzano A.M.
        • Rojas-Campos E.
        Status of renal replacement therapy and peritoneal dialysis in Mexico.
        Perit Dial Int. 2007; 27: 142-148
        • United States Renal Data System
        2018 USRDS annual data report: epidemiology of kidney disease in the United States.
        (Available at:)
        https://www.usrds.org/2018/view/Default.aspx
        Date accessed: November 18, 2018
      4. Cuenta de Alto Costo. Bogota: fondo Colombiano de enfermedades de Alto Costo.
        (Available at:)
        • Erk T.
        Success stories showing the diversity of kidney foundations: Turkish Kidney Foundation.
        Clin Nephrol. 2016; 86: 61-63
        • Abraham G.
        • Vijayan M.
        • Ravi R.
        • et al.
        The impact of kidney foundations in alleviating the burden of CKD in India—an example, Tamilnad Kidney Research Foundation.
        Clin Nephrol. 2016; 86: 74-77
        • Rashid H.U.
        • Arefin S.
        • Hasan S.
        • et al.
        The role of the Kidney Foundation of Bangladesh in promoting kidney care in a resource-limited environment.
        Clin Nephrol. 2016; 86: 64-68
        • Carter M.
        • Levin N.W.
        • Carter C.S.
        • et al.
        The Sustainable Kidney Care Foundation's contribution to the improvement of AKI management in developing countries using peritoneal dialysis.
        Clin Nephrol. 2016; 86: 78-83
        • Luyckx V.A.
        • Miljeteig I.
        • Ejigu A.M.
        • et al.
        Ethical challenges in the provision of dialysis in resource-constrained environments.
        Semin Nephrol. 2017; 37: 273-286
        • Etheredge H.
        • Paget G.
        Ethics and rationing access to dialysis in resource-limited settings: the consequences of refusing a renal transplant in the South African State sector.
        Dev World Bioeth. 2015; 15: 233-240
        • Keliddar I.
        • Mosadeghrad A.M.
        • Jafari-Sirizi M.
        Rationing in health systems: a critical review.
        Med J Islam Repub Iran. 2017; 31: 47
        • Andrade M.V.
        • Junoy J.P.
        • Andrade E.I.
        • et al.
        Allocation of initial modality for renal replacement therapy in Brazil.
        Clin J Am Soc Nephrol. 2010; 5: 637-644
        • Feehally J.
        • Brusselmans A.
        • Finkelstein F.O.
        • et al.
        Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology.
        Kidney Int Suppl. 2016; 6: 42-51
        • Calvillo-Arbizu J.
        • Roa-Romero L.M.
        • Estudillo-Valderrama M.A.
        • et al.
        User-centred design for developing e-Health system for renal patients at home (AppNephro).
        Int J Med Inform. 2019; 125: 47-54
        • Bonner A.
        • Gillespie K.
        • Campbell K.L.
        • et al.
        Evaluating the prevalence and opportunity for technology use in chronic kidney disease patients: a cross-sectional study.
        BMC Nephrol. 2018; 19: 28
        • Singh K.
        • Diamantidis C.J.
        • Ramani S.
        • et al.
        Patients' and nephrologists' evaluation of patient-facing smartphone apps for CKD.
        Clin J Am Soc Nephrol. 2019; 14: 523-529
        • Topf J.M.
        • Hiremath S.
        Got CKD? There's an app for that!.
        Clin J Am Soc Nephrol. 2019; 14: 491-492
        • Stenberg K.
        • Hanssen O.
        • Edejer T.T.
        • et al.
        Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries.
        Lancet Glob Health. 2017; 5: e875-e877
        • Essue B.M.
        • Laba M.
        • Knaul F.
        • et al.
        Economic burden of chronic ill health and injuries for households in low- and middle-income countries.
        in: Jamison D.T. Gelband H. Horton S. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd ed. The International Bank for Reconstruction and Development/The World Bank, Washington, DC2017 (chapter 6)
        • World Health Organization
        Making fair choices on the path to universal health coverage 2014.
        (Available at:)
        • World Health Organization
        Americas regional health expenditure dashboard (North, Central and South America).
        (Available at:)
        • Garcia G.G.
        • Harden P.
        • Chapman J.
        • World Kidney Day Steering Committee
        The global role of kidney transplantation.
        Lancet. 2012; 379: E36-E38
        • Correa-Rotter R.
        The cost barrier to renal replacement therapy and peritoneal dialysis in the developing world.
        Perit Dial Int. 2001; 21: S314-S317
        • Kaur G.
        • Prinja S.
        • Ramachandran R.
        • et al.
        Cost of hemodialysis in a public sector tertiary hospital of India.
        Clin Kidney J. 2018; 11: 726-733
        • Hole B.
        • Hemmelgarn B.
        • Brown E.
        • et al.
        Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world.
        Kidney Int Suppl. 2020; 10: e86-e94
        • Tantivess S.
        • Werayingyong P.
        • Chuengsaman P.
        • et al.
        Universal coverage of renal dialysis in Thailand: promise, progress, and prospects.
        BMJ. 2013; 346: f462
        • World Health Organization
        Health workforce; strategic directions.
        (Available at:)
        • Harris D.C.H.
        • Davies S.J.
        • Finkelstein F.O.
        • et al.
        Increasing access to integrated ESKD care as part of universal health coverage.
        Kidney Int. 2019; 95: S1-S33

      Linked Article

      • Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Dialysis provisions and end-stage kidney disease (ESKD) care represents an important challenge, particularly in low-resource settings. The purpose of this project was to survey nephrologists from low- and lower middle-income countries about their experiences in the following domains: (i) Dialysis funding and eligibility; (ii) dialysis-procurement mechanisms; (iii) clinical protocols for dialysis; (iv) monitoring of dialysis outcomes; and (v) barriers to care for ESKD. One hundred and twenty responses from 31 low- and middle-income countries, from 8 ISN regions, were included in the analysis.
        • Full-Text
        • PDF
      • The role of kidney transplantation as a component of integrated care for chronic kidney disease
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Kidney transplant provides superior outcomes to dialysis as a treatment for end-stage kidney disease. Therefore, it is essential that kidney transplantation be part of an integrated treatment and management plan for chronic kidney disease (CKD). Developing an effective national program of transplantation is challenging because of the requirement for kidney donors and the need for a multidisciplinary team to provide expert care for both donors and recipients. This article outlines the steps necessary to establish a national kidney transplant program, starting with the requirement for effective legislation that provides the legal framework for transplantation whilst protecting organ donors, their families, recipients, and staff and is an essential requirement to combat organ trafficking.
        • Full-Text
        • PDF
      • Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.
        • Full-Text
        • PDF
      • Global case studies for chronic kidney disease/end-stage kidney disease care
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          The prevalence of chronic kidney disease and its risk factors is increasing worldwide, and the rapid rise in global need for end-stage kidney disease care is a major challenge for health systems, particularly in low- and middle-income countries. Countries are responding to the challenge of end-stage kidney disease in different ways, with variable provision of the components of a kidney care strategy, including effective prevention, detection, conservative care, kidney transplantation, and an appropriate mix of dialysis modalities.
        • Full-Text
        • PDF
      • Framework for establishing integrated kidney care programs in low- and middle-income countries
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Secular increases in the burden of kidney failure is a major challenge for health systems worldwide, especially in low- and middle-income countries (LMICs) due to growing demand for expensive kidney replacement therapies. In LMICs with limited resources, the priority of providing kidney replacement therapies must be weighed against the prevention and treatment of chronic kidney disease, other kidney disorders such as acute kidney injury, and other noncommunicable diseases, as well as other urgent public health needs.
        • Full-Text
        • PDF
      • Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          A key component of treatment for all people with advanced kidney disease is supportive care, which aims to improve quality of life and can be provided alongside therapies intended to prolong life, such as dialysis. This article addresses the key considerations of supportive care as part of integrated end-stage kidney disease care, with particular attention paid to programs in low- and middle-income countries. Supportive care should be an integrated component of care for patients with advanced chronic kidney disease, patients receiving kidney replacement therapy (KRT), and patients receiving non-KRT conservative care.
        • Full-Text
        • PDF
      • Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Substantial heterogeneity in practice patterns around the world has resulted in wide variations in the quality and type of dialysis care delivered. This is particularly so in countries without universal standards of care and governmental (or other organizational) oversight. Most high-income countries have developed such oversight based on documentation of adherence to standardized, evidence-based guidelines. Many low- and lower-middle-income countries have no or only limited organized oversight systems to ensure that care is safe and effective.
        • Full-Text
        • PDF
      • Developing the ethical framework of end-stage kidney disease care: from practice to policy
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Ethical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care.
        • Full-Text
        • PDF
      • Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          Prevention and early detection of kidney diseases in adults and children should be a priority for any government health department. This is particularly pertinent in the low-middle-income countries, mostly in Asia, Africa, Latin America, and the Caribbean, where up to 7 million people die because of lack of end-stage kidney disease treatment. The nephrology workforce (nurses, technicians, and doctors) is limited in these countries and expanding the size and expertise of the workforce is essential to permit expansion of treatment for both chronic kidney disease and end-stage kidney disease.
        • Full-Text
        • PDF
      • The second Global Kidney Health Summit outputs: developing a strategic plan to increase access to integrated end-stage kidney disease care worldwide
        Kidney International SupplementsVol. 10Issue 1
        • Preview
          The articles in this edition of Kidney International Supplements describe the background, rationale, and action plans for developing a strategic approach to increase access to integrated end-stage kidney disease (ESKD) care worldwide over the next decade. It is estimated that the number of people dying globally with ESKD for want of kidney replacement therapy is up to 3 times the number who receive it.1 Kidney transplantation meets only a small fraction of this therapeutic need. Many patients with advanced kidney disease, whether receiving kidney replacement therapy or not, suffer considerably because they have no access to supportive care.
        • Full-Text
        • PDF